|
Volumn 63, Issue 5, 2010, Pages 762-768
|
Long-term etanercept in pediatric patients with plaque psoriasis
|
Author keywords
efficacy; etanercept; long term treatment; pediatric patients; plaque psoriasis; safety
|
Indexed keywords
ETANERCEPT;
PLACEBO;
ABNORMAL LABORATORY RESULT;
ACNE;
ADOLESCENT;
ARTICLE;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
DISEASE ACTIVITY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG FATALITY;
DRUG FEVER;
DRUG INDUCED CANCER;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
INJECTION SITE REACTION;
LEUKOCYTE COUNT;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NOSE CONGESTION;
OPPORTUNISTIC INFECTION;
PATIENT COMPLIANCE;
PHARYNGITIS;
PHYSICIAN GLOBAL ASSESSMENT;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PSORIASIS SEVERITY INDEX;
PSORIASIS VULGARIS;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
RHINOPHARYNGITIS;
SCHOOL CHILD;
SIDE EFFECT;
SINUSITIS;
SKIN PAPILLOMA;
SORE THROAT;
STREPTOCOCCAL PHARYNGITIS;
THROMBOCYTE;
TREATMENT RESPONSE;
UPPER RESPIRATORY TRACT INFECTION;
ADOLESCENT;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
PSORIASIS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECEPTORS, TUMOR NECROSIS FACTOR;
SEVERITY OF ILLNESS INDEX;
SKIN;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 77957990805
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaad.2010.04.004 Document Type: Article |
Times cited : (83)
|
References (10)
|